InvestorsHub Logo
Followers 505
Posts 10140
Boards Moderated 0
Alias Born 04/28/2014

Re: None

Sunday, 06/29/2014 11:14:50 AM

Sunday, June 29, 2014 11:14:50 AM

Post# of 6012
Rafarma Pharmaceuticals, Inc. (WY) [$RAFA] due diligence

bullish

$RAFA

DD Notes ~ http://www.ddnotesmaker.com/RAFA

##### recent news/filings ~ source: finance.yahoo.com

Mon, 12 May 2014 13:15:00 GMT ~ Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials
[GlobeNewswire] - MOSCOW -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to upgrading its public stock listing. ...
read full: http://finance.yahoo.com/news/rafarma-pharmaceuticals-rafa-commences-preparation-131500911.html
*********************************************************

Thu, 24 Apr 2014 09:41:26 GMT ~ 4 Pharmaceuticals With Significant Potential
read full: http://seekingalpha.com/article/2160093-4-pharmaceuticals-with-significant-potential?source=yahoo
*********************************************************

Thu, 10 Apr 2014 13:10:00 GMT ~ Rafarma Pharmaceuticals (OTC:RAFA) Announces Significant Cash Flow Improvement Through Restructuring
[PR Newswire] - MOSCOW, April 10, 2014 /PRNewswire/ -- In response to shareholder inquiries, CEO Dave Anderson offers further comment on the improved financial position of Rafarma: Another very significant element is an additional credit line of € 25,000,000 (EUR). Both elements essentially create "new money" through the restructuring process. The additional credit line will allow for accelerated production, licensing and deployment of the pharmaceutical products currently in development. Mr. Anderson commented further: "This restructuring has come at the most opportune time in the development of the company.
read full: http://finance.yahoo.com/news/rafarma-pharmaceuticals-otc-rafa-announces-131000627.html
*********************************************************

Wed, 02 Apr 2014 15:00:00 GMT ~ Restructuring offers Assurance of Rafarma Pharmaceuticals' Improved Financial Future
[PR Newswire] - MOSCOW, April 2, 2014 /PRNewswire/ -- Rafarma Pharmaceuticals Inc. (OTC RAFA) is pleased to announce the complete restructuring of its existing € 90,000,000.00 loan with VNeshconombank (VEBank), Russia's premier development bank. Company CEO Dave Anderson stated, "We are gratified that VEBank have arranged this three year deferral and feel this offers a validation of management's progressive plan and meaningful support to Rafarma's stated objective of becoming a leading pharmaceutical company in Europe. The original loan from VEB was used in the construction of the company's 270,000 square foot state-of-the-art production facility in Terbuny. For the last three years, the Russian Government has been highly focused on bolstering the development of the nation's domestic pharmaceutical industry.
read full: http://finance.yahoo.com/news/restructuring-offers-assurance-rafarma-pharmaceuticals-131000348.html
*********************************************************

Wed, 05 Feb 2014 13:00:00 GMT ~ Rafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry
[PR Newswire] - MOSCOW, Feb. 5, 2014 /PRNewswire/ -- On February 3, 2014, ZAO Rafarma management met with senior faculty members of the St. Petersburg Academy of Pharmaceutical Chemistry to create a long-term cooperative ...
read full: http://finance.yahoo.com/news/rafarma-pharmaceuticals-otc-rafa-announces-130000916.html
*********************************************************

##### chart ~ source: stockcharts.com



##### chart ~ source: eoddata.com



##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/RAFA/company-info
Ticker: $RAFA
OTC Market Place: OTC Pink Current
CIK code: 0001120569
Company name: Rafarma Pharmaceuticals, Inc. (WY)
Company website: http://www.rafarma.com
Incorporated In: WY, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001120569&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/RAFA/filings
Latest financials: http://www.otcmarkets.com/stock/RAFA/financials
Latest news: http://www.otcmarkets.com/stock/RAFA/news - http://finance.yahoo.com/q/h?s=RAFA+Headlines

Major holdings: http://data.cnbc.com/quotes/RAFA/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=RAFA+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/RAFA.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=RAFA

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=RAFA&search=search

DTCC: http://search2.dtcc.com/?q=Rafarma+Pharmaceuticals%2C+Inc.+%28WY%29&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Rafarma+Pharmaceuticals%2C+Inc.+%28WY%29
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Rafarma+Pharmaceuticals%2C+Inc.+%28WY%29&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.rafarma.com
Alexa: http://www.alexa.com/siteinfo/http://www.rafarma.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.rafarma.com

Short Sales: http://www.otcmarkets.com/stock/RAFA/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/RAFA/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/RAFA/research
Historical Prices: http://finance.yahoo.com/q/hp?s=RAFA+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=RAFA+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=RAFA+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=RAFA+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=RAFA+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=RAFA+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=RAFA
Balance Sheet: http://finance.yahoo.com/q/bs?s=RAFA
Cash Flow: http://finance.yahoo.com/q/cf?s=RAFA+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/RAFA
Bloomberg: http://www.bloomberg.com/quote/RAFA:US
Morningstar: http://quotes.morningstar.com/stock/s?t=RAFA
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RAFA
Barchart: http://www.barchart.com/quotes/stocks/RAFA
OTC Short Report: http://otcshortreport.com/index.php?index=RAFA
Investopedia: http://www.investopedia.com/markets/stocks/RAFA/?wa=0

http://www.pennystocktweets.com/stocks/profile/RAFA

##### last known share structure ~ source: otcmarkets.com

Market Value: $12,427,339 a/o Jun 27, 2014
Shares Outstanding: 77,670,870 a/o Dec 15, 2013
Float: 1,662,687 a/o Jun 27, 2013
Authorized Shares: 300,000,000 a/o Dec 15, 2013
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Rafarma owns and operates a multi-profile pharmaceutical plant with the ability to produce all types medical drugs in all delivery methods for various pharmacological groups. The plant was constructed on the territory of a special industrial economic zone in Terbuny of the Lipetsk region of Russia. In 2012, the Ministry of Industry and Trade of the Russian Federation listed Rafarma as one of the leading and most promising projects in the modern Russian pharmaceutical and medical industry.

DD Notes ~ http://www.ddnotesmaker.com/RAFA
cb0c